Skip to content

Relation of C-reactive Protein/ Albumin Ratio and Coagulation Profile in Acute Myeloid Leukemia Patients

Relation of C-reactive Protein/ Albumin Ratio and Coagulation Profile in Acute Myeloid Leukemia Patients

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06714071
Enrollment
80
Registered
2024-12-03
Start date
2025-04-30
Completion date
2027-05-01
Last updated
2025-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

AML

Brief summary

The investigators will investigate the relation between CAR and coagulation profile in newly diagnosed AMl patients

Detailed description

Acute myeloid leukaemia (AML) is an aggressive haematological malignancy with a high degree of heterogeneity. It has long been recognized that systemic inflammation is associated with tumorigenesis it revealed that elevated C-reactive protein levels were associated with worse survival outcomes in patients with various types of cancer, including hematologic malignancies. Serum albumin is a measure of an individual's nutritional status. Systemic inflammation can reduce serum albumin concentrations by increasing capillary permeability . The ratio of CRP to albumin (CAR) is a useful score based on inflammation and nutrition, reflecting not only systemic inflammation status but also nutritional status. The Glasgow prognostic score (GPS) and modified GPS (mGPS), determined by the serum CRP and albumin levels, have been proposed as prognostic indicators for AML patients. However, the clinical correlations of CAR and its prognostic value in AML patients have not yet been clarified. Abnormalities of hemostasis can occur in leukemia in the form of disseminated intravascular coagulation(DIC), coagulation protein defect and primary fibrinolysis . Clinically, Types of acute myeloid leukemia like acute promyelocyticleukemia has a high frequency of haemorrhage due to disseminated intravascular coagulation (DIC), which contributes to the high mortality rate of this disease . Therefore, the investigators will investigate CAR its relation with inflammatory response and coagulation profile levels in newly diagnosed acute myeloid leukemia and after 3 month follow up to compare their level and the relation between .

Interventions

DIAGNOSTIC_TESTCRP and Albumin and coagulation profile

CRP and Albumin and coagulation profile

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

\- all cases newly diagnosed with acute myeloid leukemiain assuit university hospital

Exclusion criteria

1. cases with chronic myeloid leukemia 2. cases with acute lymphoblasticleukemia

Design outcomes

Primary

MeasureTime frameDescription
Correlation between C- reactive protein and coagulation profile in AML patientsStudy complete an average 2 yearsthe investigators will investigate the correlation between CAR and coagulation profile in newly diagnosed AMl patients by measure crp and coagulation profile in newly diagnosed patient and up to 3 month follow up

Countries

Egypt

Contacts

Primary Contactshrouk mosallam, master
shrouqmosllam@gmail.com01014396113
Backup Contacthebatallah addellatif, prof
hebatallah.abdellatif@aun.edu.eg01006829911

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026